Previous close | 87.20 |
Open | 34.62 |
Bid | 89.00 |
Ask | 93.50 |
Strike | 155.00 |
Expiry date | 2024-05-17 |
Day's range | 34.62 - 87.20 |
Contract range | N/A |
Volume | |
Open interest | 15 |
Inspire Reports Year-over-YearRevenue Growth of 28% in the First Quarter and Expects Profitability for the Full Year 2024 MINNEAPOLIS, May 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended March 31, 2024. Recent Business Highlights Generated reven
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how INSP, MCK, FMS, NVRO and INGN are placed ahead of their earnings releases.
Get a deeper insight into the potential performance of Inspire (INSP) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.